Monthly reportNDA
National Drug Authority — August 2018
What this register recorded from NDA in August 2018, what other African authorities published in the same month that bears on it, and what we could not read in NDA’s own notices. Every figure here is a count of published regulatory actions. None of it is a finding about National Drug Authority.
What NDA published
| Reference | Date | Country | Product | Batches | Action | Class | Source |
|---|---|---|---|---|---|---|---|
| DEA-UG-2018-44654198 | Aug 2018 | UG | Increased risk of non-melanoma skin cancer associated with HCTZ | none published | Safety communication | Unclassified | Tier 1 · Regulator-published |
| DEA-UG-2018-79023705 | 31 Aug 2018 | UG | Risk of crystalization of Mannitol 20% iv solution | none published | Safety communication | Unclassified | Tier 1 · Regulator-published |
What other authorities published
What we could not read in NDA’s notices
- 40 record(s) held from NDA in total
- 1 carry no publication date we could read
- 35 name neither a batch nor a stated reason
- 39 name no manufacturer
- 35 are searchable and API-available but carry noindex, because they are too incomplete for a public URL
- 1 have no archived copy of the original notice
Correcting this
Anything on this page that is wrong about National Drug Authority can be corrected by National Drug Authority, and a record published by one of its officers carries verification tier 0 — the rank only the issuing regulator can create. Nothing else on this register does.